Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Aitken

Showing results (171-180 of 340) with videos related to

Pageof 34
Sort By:
Clinical Pharmacology and Therapeutics|December 1, 1991
Disposition of drugs in cystic fibrosis. III. AcetaminophenR M Hutabarat, J D Unadkat, P Kushmerick, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|March 15, 2021
Efficacy and safety of inhaled dry-powder mannitol in adults with cystic fibrosis: An international, randomized controlled studyPatrick A Flume, Elena Amelina, Cori L Daines, et al.
American Journal of Respiratory and Critical Care Medicine|September 18, 2012
Disparities in access to lung transplantation for patients with cystic fibrosis by socioeconomic statusBradley S Quon, Kevin Psoter, Nicole Mayer-Hamblett, et al.
Leukemia & Lymphoma|June 13, 2020
Incidence and characterization of fungal infections in chronic lymphocytic leukemia patients receiving ibrutinibMichael Frei, Samuel L Aitken, Nitin Jain, et al.
The American Surgeon|November 14, 2025
The Impact of Race and Socioeconomic Status on Management of Potentially Resectable Pancreatic Cancer: Analysis From a Metropolitan Area in the Southeast United StatesDevanshi D Patel, Samantha Brashier, Andrew M Fleming, et al.
Human Gene Therapy|April 14, 2006
Prevalence of neutralizing antibodies against adeno-associated virus (AAV) types 2, 5, and 6 in cystic fibrosis and normal populations: Implications for gene therapy using AAV vectorsChristine L Halbert, A Dusty Miller, Sharon McNamara, et al.
Epidemiology and Infection|May 10, 2018
Outcomes associated with Clostridium difficile infection in patients with chronic liver diseaseKierra M Dotson, Samuel L Aitken, Amelia K Sofjan, et al.
Journal of Applied Behavior Analysis|July 1, 1997
The use of positive and negative reinforcement in the treatment of escape-maintained destructive behaviorC C Piazza, W W Fisher, G P Hanley, et al.
Journal of Virology|August 1, 1997
Transduction by adeno-associated virus vectors in the rabbit airway: efficiency, persistence, and readministrationC L Halbert, T A Standaert, M L Aitken, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 5, 2021
Infectious Diseases Society of America Guidance on the Treatment of AmpC β-Lactamase-Producing Enterobacterales, Carbapenem-Resistant Acinetobacter baumannii, and Stenotrophomonas maltophilia InfectionsPranita D Tamma, Samuel L Aitken, Robert A Bonomo, et al.
Pageof 34

Showing results (171-180 of 340) with videos related to

Sort By:
Pageof 34
Clinical Pharmacology and Therapeutics|December 1, 1991
Disposition of drugs in cystic fibrosis. III. AcetaminophenR M Hutabarat, J D Unadkat, P Kushmerick, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|March 15, 2021
Efficacy and safety of inhaled dry-powder mannitol in adults with cystic fibrosis: An international, randomized controlled studyPatrick A Flume, Elena Amelina, Cori L Daines, et al.
American Journal of Respiratory and Critical Care Medicine|September 18, 2012
Disparities in access to lung transplantation for patients with cystic fibrosis by socioeconomic statusBradley S Quon, Kevin Psoter, Nicole Mayer-Hamblett, et al.
Leukemia & Lymphoma|June 13, 2020
Incidence and characterization of fungal infections in chronic lymphocytic leukemia patients receiving ibrutinibMichael Frei, Samuel L Aitken, Nitin Jain, et al.
The American Surgeon|November 14, 2025
The Impact of Race and Socioeconomic Status on Management of Potentially Resectable Pancreatic Cancer: Analysis From a Metropolitan Area in the Southeast United StatesDevanshi D Patel, Samantha Brashier, Andrew M Fleming, et al.
Human Gene Therapy|April 14, 2006
Prevalence of neutralizing antibodies against adeno-associated virus (AAV) types 2, 5, and 6 in cystic fibrosis and normal populations: Implications for gene therapy using AAV vectorsChristine L Halbert, A Dusty Miller, Sharon McNamara, et al.
Epidemiology and Infection|May 10, 2018
Outcomes associated with Clostridium difficile infection in patients with chronic liver diseaseKierra M Dotson, Samuel L Aitken, Amelia K Sofjan, et al.
Journal of Applied Behavior Analysis|July 1, 1997
The use of positive and negative reinforcement in the treatment of escape-maintained destructive behaviorC C Piazza, W W Fisher, G P Hanley, et al.
Journal of Virology|August 1, 1997
Transduction by adeno-associated virus vectors in the rabbit airway: efficiency, persistence, and readministrationC L Halbert, T A Standaert, M L Aitken, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 5, 2021
Infectious Diseases Society of America Guidance on the Treatment of AmpC β-Lactamase-Producing Enterobacterales, Carbapenem-Resistant Acinetobacter baumannii, and Stenotrophomonas maltophilia InfectionsPranita D Tamma, Samuel L Aitken, Robert A Bonomo, et al.
Pageof 34